Development of prilling process for biodegradable microspheres through experimental designs

Int J Pharm. 2016 Feb 10;498(1-2):96-109. doi: 10.1016/j.ijpharm.2015.11.051. Epub 2015 Dec 2.

Abstract

The prilling process proposes a microparticle formulation easily transferable to the pharmaceutical production, leading to monodispersed and highly controllable microspheres. PLGA microspheres were used for carrying an encapsulated protein and adhered stem cells on its surface, proposing a tool for regeneration therapy against injured tissue. This work focused on the development of the production of PLGA microspheres by the prilling process without toxic solvent. The required production quality needed a complete optimization of the process. Seventeen parameters were studied through experimental designs and led to an acceptable production. The key parameters and mechanisms of formation were highlighted.

Keywords: Experimental design; Glycofurol; Microsphere; PLGA; Prilling.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Chemistry, Pharmaceutical / methods*
  • Chickens
  • Drug Design
  • Lactic Acid / chemical synthesis*
  • Lactic Acid / pharmacokinetics
  • Micrococcus* / metabolism
  • Microspheres*
  • Muramidase / chemistry*
  • Muramidase / pharmacokinetics
  • Particle Size
  • Polyethylene Glycols / chemical synthesis*
  • Polyethylene Glycols / pharmacokinetics
  • Polyglycolic Acid / chemical synthesis*
  • Polyglycolic Acid / pharmacokinetics
  • Polylactic Acid-Polyglycolic Acid Copolymer

Substances

  • Polylactic Acid-Polyglycolic Acid Copolymer
  • Polyglycolic Acid
  • Lactic Acid
  • Polyethylene Glycols
  • Muramidase
  • glycofurol